1. Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
   Tania Reyes-Vallejo et al, 2022, OncoTargets and Therapy CrossRef
2. Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
   Rajib K. Shil et al, 2024, Frontiers in Immunology CrossRef
3. Features and prognostic significance of soluble TIM-3 and its ligands Gal-9 and CEACAM1 levels in the diagnostic bone marrow of adult acute myeloid leukemia patients
   Zong-Yan Shi et al, 2024, Journal of Leukocyte Biology CrossRef
4. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion
   Cansu Yıldırım, 2024, Molecular Biology Reports CrossRef
5. The role of galectins in mediating the adhesion of circulating cells to vascular endothelium
   Joseph Souchak et al, 2024, Frontiers in Immunology CrossRef
6. Human T cell glycosylation and implications on immune therapy for cancer
   Elien De Bousser et al, 2020, Human Vaccines & Immunotherapeutics CrossRef